ALL SIGNATURE SERIES

12th Annual BCLT Privacy Law Forum

Sponsor: BCLT
With the rapid development of privacy and cybersecurity law, keeping up with the law is not enough to guide your company and clients. You need to know best practices. You need to understand what your peers are doing and planning to do. BCLT has gathered leading privacy experts to offer fresh insight and practical advice on meeting urgent privacy challenges. New programming format: US & Global focus with online viewing! This year's BCLT Privacy Law Forum offers programming tailored to your specific interest and focus areas, including two half-days of EU and UK expert panelists.

24th Annual Berkeley-Stanford Advanced Patent Law Institute

Sponsor: BCLT
The launch of the UPC could significantly alter patent law around the world. Whether you are a patent litigator, a patent prosecutor, or product counsel you need to understand this new global landscape and the impact that it could have on your existing domestic practices. This year, we bring you a special focus on the future of innovation protection in this changing environment. We have an intriguing fireside chat between the Director of the United States Patent Office and the Director of the Canadian Intellectual Property Office. We also have two keynotes from leading global jurists and thought leaders on protecting innovation: Hon. Dr. Klaus Grabinski, the President of the UPC Court of Appeal, and Lord Justice Colin Birss, U.K.’s Deputy Head of Civil Justice.

2nd BCLT Advanced Life Sciences Institute

Sponsor: BCLT
Rapid advancement in life sciences technologies has made keeping up with the legal implications more important than ever. Join us for the 2nd BCLT Advanced Life Sciences Institute, where you will learn from the experts about cutting-edge issues impacting your life sciences practice. Our programming will share key insights and best practices related to the rapid rise of AI in the life sciences and new trends for licensing, deals, and life sciences funding models. We will also have experts reviewing key developments in the law (Section 112, obviousness-type double patenting), anti-counterfeiting and patient safety, and the ever-complex interplay of regulatory and IP exclusivities. Finally, don’t miss our in-depth discussions on future pandemic preparedness and use of trade secrets v. patents for portfolio protection!